The market is dominated by foreign suppliers, as imports account for 64.0% of total market size in 2020. B2B drives market demand, with B2B spending representing 91.0% of total demand in 2020. The UK has the third largest market size for pharmaceuticals in the region, with demand reaching USD61.6 billion in 2020. GlaxoSmithKline Plc is the largest company in the UK, generating 7.9% of the industry’s total production value in 2020. The industry is fragmented, with the top five companies generating 19.4% of total production value in 2020. The total number of companies increases in 2020, to 7,255 units. The costs of the industry increase by 21.2% in 2020, largely driven by rising B2B costs. The industry’s profitability decreases and stands at 14.3% of production value in 2020, the 15th highest in the region. The industry’s exports share increases in 2020 to 57.9% of total production output. With production value of USD47.1 billion, the UK accounts for 9.3% of the Western Europe total in 2020.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This Euromonitor industrial report provides unique information on Pharmaceuticals in the UK: ISIC 2423. With this industrial report, you’ll be able to explore the industry from its sources of supply to its buyers. The Pharmaceuticals in the UK: ISIC 2423 report includes: Industry datagraphics including production data, exports, imports, cost structure, and profitability
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page